Crossmark

GPD1L may inhibit the development of esophageal squamous cell carcinoma through the PI3K/AKT signaling pathway: bioinformatics analysis and experimental exploration

Crossref DOI link: https://doi.org/10.1007/s11033-024-10070-1

Published Online: 2024-11-13

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gan, LanLan

Zhou, Lu

Chu, ALan

Sun, Chen

Wang, YongTai

Yang, MengLin

Liu, ZongWen
License Information

Text and Data Mining valid from 2024-11-13

Version of Record valid from 2024-11-13
More Information

Article History

Received: 1 August 2024

Accepted: 28 October 2024

First Online: 13 November 2024

Declarations

:

: This study was approved by the Medical Ethics Committee of the Second Affiliated Hospital of Zhengzhou University (approval no.2023201).

: The authors declare no competing interests.

Document is current

Any future updates will be listed below